DNA repair and recombination within the var gene family of P. falciparum

恶性疟原虫 var 基因家族内的 DNA 修复和重组

基本信息

  • 批准号:
    8712356
  • 负责人:
  • 金额:
    $ 42.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-24 至 2017-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Malaria is caused by protozoan parasites of the genus Plasmodium. P. falciparum is the most virulent species and is responsible for the majority of both morbidity and mortality, including approximately 800,000 deaths per year that occur mainly among young children. Key to the parasite's ability to survive attack by the host's immune system is its ability to repair DNA damage. DNA double strand breaks (DSBs) are lethal if not repaired, and malaria parasites appear to be missing one of the two primary pathways used by most eukaryotes to repair such breaks. In addition, the remaining pathway requires a second DNA copy homologous to the site of the break to serve as a template for repair. Considering that malaria parasites are haploid for most of their lifecycle and therefore the majority of the genome is maintained as a single copy, how they repair DSBs remains a mystery. The long-term objectives of this proposal are to understand how parasites maintain the integrity of their genomes, and to determine how DNA repair pathways contribute to diversification of the genes encoding their primary surface antigens. To address these objectives, a regulatable, site-specific endonuclease system has been adapted for use in cultured parasites. This system enables the induction of a single DSB within a targeted site of the genome followed by the rapid and efficient isolation of the products of repair. In the first ai of the project, this system will be used to characterize the basic mechanisms employed by parasites to repair DSBs, including how error prone the process is, whether a template is required, and the role of the mismatch repair pathway in DSB repair. In the second aim, the system will be applied to investigating diversification of the var gene family. var genes encode PfEMP1, the primary malaria virulence factor. This large, multi-copy gene family undergoes rapid and continuous diversification that enables the parasite to avoid the immune system through antigenic variation. The mechanisms underlying diversification are unknown, but the process appears to involve frequent "shuffling" of segments, a hallmark of gene conversion events that are a product of DSB repair. The site-specific endonuclease system will be used to determine how DSB repair contributes to var gene diversification.
描述(由申请人提供):疟疾由疟原虫属的原生动物寄生虫引起。 恶性疟原虫是毒性最强的物种,是造成大部分发病率和死亡率的原因,其中每年约有800,000人死亡,主要发生在幼儿中。寄生虫能够在宿主免疫系统的攻击下存活的关键是它修复DNA损伤的能力。DNA双链断裂(DSB)如果不修复是致命的,疟疾寄生虫似乎缺少大多数真核生物修复这种断裂的两个主要途径之一。此外,剩余的通路需要与断裂位点同源的第二个DNA拷贝作为修复的模板。考虑到疟疾寄生虫在其生命周期的大部分时间里都是单倍体,因此大部分基因组都是以单拷贝的形式维持的,它们如何修复DSB仍然是一个谜。该提案的长期目标是了解寄生虫如何保持其基因组的完整性,并确定DNA修复途径如何有助于编码其主要表面抗原的基因的多样化。为了实现这些目标,一种可调节的、位点特异性内切核酸酶系统已被改造用于培养的寄生虫。该系统能够在基因组的靶位点内诱导单个DSB,然后快速有效地分离修复产物。在该项目的第一个人工智能中,该系统将用于表征寄生虫修复DSB的基本机制,包括该过程如何容易出错,是否需要模板以及错配修复途径在DSB修复中的作用。在第二个目标中,该系统将被应用于研究var基因家族的多样性。var基因编码PfEMP 1,主要的疟疾毒力因子。这个庞大的多拷贝基因家族经历了快速和持续的多样化,使寄生虫能够通过抗原变异避开免疫系统。多样化背后的机制尚不清楚,但这一过程似乎涉及片段的频繁“洗牌”,这是DSB修复产物基因转换事件的标志。位点特异性内切核酸酶系统将用于确定DSB修复如何有助于var基因多样化。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kirk W Deitsch其他文献

The mystery of persistent, asymptomatic emPlasmodium falciparum/em infections
  • DOI:
    10.1016/j.mib.2022.102231
  • 发表时间:
    2022-12-01
  • 期刊:
  • 影响因子:
    7.500
  • 作者:
    Xu Zhang;Kirk W Deitsch
  • 通讯作者:
    Kirk W Deitsch

Kirk W Deitsch的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kirk W Deitsch', 18)}}的其他基金

2022 Biology of Host-Parasite Interactions GRC and GRS
2022年寄主与寄生虫相互作用的生物学GRC和GRS
  • 批准号:
    10461307
  • 财政年份:
    2022
  • 资助金额:
    $ 42.25万
  • 项目类别:
A structured transcriptional switching network that coordinates antigenic variation by malaria parasites
协调疟原虫抗原变异的结构化转录转换网络
  • 批准号:
    10319714
  • 财政年份:
    2021
  • 资助金额:
    $ 42.25万
  • 项目类别:
Mechanisms of environmental sensing and responses by malaria parasites
疟原虫的环境感知和响应机制
  • 批准号:
    10160766
  • 财政年份:
    2018
  • 资助金额:
    $ 42.25万
  • 项目类别:
Mechanisms of environmental sensing and responses by malaria parasites
疟原虫的环境感知和响应机制
  • 批准号:
    10409750
  • 财政年份:
    2018
  • 资助金额:
    $ 42.25万
  • 项目类别:
DNA repair and recombination within the var gene family of P. falciparum
恶性疟原虫 var 基因家族内的 DNA 修复和重组
  • 批准号:
    8896210
  • 财政年份:
    2012
  • 资助金额:
    $ 42.25万
  • 项目类别:
DNA repair and recombination within the var gene family of P. falciparum
恶性疟原虫 var 基因家族内的 DNA 修复和重组
  • 批准号:
    8438018
  • 财政年份:
    2012
  • 资助金额:
    $ 42.25万
  • 项目类别:
DNA repair and recombination within the var gene family of P. falciparum
恶性疟原虫 var 基因家族内的 DNA 修复和重组
  • 批准号:
    8549946
  • 财政年份:
    2012
  • 资助金额:
    $ 42.25万
  • 项目类别:
DNA repair and recombination within the var gene family of P. falciparum
恶性疟原虫 var 基因家族内的 DNA 修复和重组
  • 批准号:
    9120780
  • 财政年份:
    2012
  • 资助金额:
    $ 42.25万
  • 项目类别:
DNA repair and recombination within the var gene family of P. falciparum
恶性疟原虫 var 基因家族内的 DNA 修复和重组
  • 批准号:
    8898709
  • 财政年份:
    2012
  • 资助金额:
    $ 42.25万
  • 项目类别:
Var gene regulation and antigenic variation in malaria
疟疾中的 Var 基因调控和抗原变异
  • 批准号:
    7234045
  • 财政年份:
    2002
  • 资助金额:
    $ 42.25万
  • 项目类别:

相似国自然基金

基于构建骨骼类器官模型探究Fanconi anemia信号通路调控电刺激诱导神经化成骨过程的机制研究
  • 批准号:
    82302715
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
FANCM蛋白在传统Fanconi anemia通路以外对保护基因组稳定性的功能
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
范可尼贫血(Fanconi Anemia)基因FANCM在复制后修复中的作用及FA癌症抑制通路的机制研究
  • 批准号:
    31200592
  • 批准年份:
    2012
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Investigation of crosstalk between Fanconi Anemia pathway and ATM for novel therapeutic strategies of chemoresistant ALT-positive high-risk neuroblastoma
范可尼贫血通路与 ATM 之间的串扰研究,用于化疗耐药 ALT 阳性高危神经母细胞瘤的新治疗策略
  • 批准号:
    24K10442
  • 财政年份:
    2024
  • 资助金额:
    $ 42.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Immune escape mechanisms in BCOR/BCORL1 mutant hematopoietic stem cells from patients with aplastic anemia
再生障碍性贫血患者 BCOR/BCORL1 突变型造血干细胞的免疫逃逸机制
  • 批准号:
    23K15297
  • 财政年份:
    2023
  • 资助金额:
    $ 42.25万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Fanconi anemia経路に着目したiPS細胞における高レベル複製ストレスの原因解明
阐明 iPS 细胞中高水平复制应激的原因,重点关注范可尼贫血途径
  • 批准号:
    23K14452
  • 财政年份:
    2023
  • 资助金额:
    $ 42.25万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Analysis of the mechanism of hemolytic anemia in canine babesiosis and development of novel therapeutic measures
犬巴贝斯虫病溶血性贫血机制分析及新治疗措施开发
  • 批准号:
    23KJ0074
  • 财政年份:
    2023
  • 资助金额:
    $ 42.25万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Brain blood flow, oxygenation, and cognition in adult onset iron deficiency anemia
成人缺铁性贫血的脑血流量、氧合和认知
  • 批准号:
    10735765
  • 财政年份:
    2023
  • 资助金额:
    $ 42.25万
  • 项目类别:
Chromatin State Alterations in Fanconi Anemia Hematologic Disease and Bone Marrow Failure
范可尼贫血血液疾病和骨髓衰竭中的染色质状态改变
  • 批准号:
    10735366
  • 财政年份:
    2023
  • 资助金额:
    $ 42.25万
  • 项目类别:
Liver-Gut Axis in Neonatal Anemia and Its Role in RBC Transfusion Associated Gut Injury
新生儿贫血中的肝肠轴及其在红细胞输注相关肠道损伤中的作用
  • 批准号:
    10583807
  • 财政年份:
    2023
  • 资助金额:
    $ 42.25万
  • 项目类别:
Small Molecule Therapeutics for Sickle Cell Anemia
镰状细胞性贫血的小分子疗法
  • 批准号:
    10601679
  • 财政年份:
    2023
  • 资助金额:
    $ 42.25万
  • 项目类别:
Accuracy and Feasibility of Non-Invasive Anemia Screening Assistant (ASIST) Device in Resource-Limited Settings
资源有限环境中非侵入性贫血筛查辅助 (ASIST) 设备的准确性和可行性
  • 批准号:
    10575222
  • 财政年份:
    2023
  • 资助金额:
    $ 42.25万
  • 项目类别:
Mobile phone-based screening for anemia in young children in western Kenya
基于手机的肯尼亚西部幼儿贫血筛查
  • 批准号:
    10752968
  • 财政年份:
    2023
  • 资助金额:
    $ 42.25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了